SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (156)8/19/2002 10:54:21 PM
From: tuck  Read Replies (1) of 447
 
Want to see how focused they are on diabetes and other indications outside of cancer? This table of their pipeline is from their latest 10-K:


  >>DISEASE AREA/PRODUCT                  DRUG TYPE                 STATUS(a)    COLLABORATOR
  --------------------                  ---------                 ---------    ------------
Cancer
  Tarceva(TM)              Epidermal growth factor receptor       Phase III   Genentech/Roche
                             inhibitor
  NX211                    Liposomal lurtotecan                   Phase II     OSI-Owned(b)
  GS7836                   Gemzar(R) analog                        Phase I     OSI-Owned(b)
  CP-609,754               Farnesyl transferase inhibitor          Phase I       OSI-Owned
  CP-632                   Vascular endothelial growth factor      Phase I        Pfizer
                             receptor
  GS7904L                  Liposomal thymidycate                   Phase I     OSI-Owned(b)
  CP-XXX                   HER2-neu                               IND Track       Pfizer
  CP-XXX                   PDGFr                                  IND Track       Pfizer
Respiratory/Asthma
  OSI-760                  Adenosine A(1) receptor inhibitor      IND Track      OSI-Owned
  AVE0309                  Interleukin-4 gene expression          IND Track       Aventis
                             inhibitor
Cholesterol Lowering
  HMR 1171/                Low density lipoprotein receptor       IND Track       Aventis
  AVE 9103A                  gene expression stimulator
Congestive Heart Failure
  OSIC-0961370             Adenosine A(1) receptor inhibitor      IND Track       Solvay
  AVE9488                  EcNOS gene expression inhibitor        IND Track       Aventis<<


Tom, do not trust Yahoo! profiles. They are a starting point only.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News